Medical doctorProthya BiosolutionsNew York, New York, United States
PB0554 - A phase 1/2 study to determine the dose-response relationship by assessment of thrombin generation after 4-factor PCC in healthy subjects under vitamin K antagonist anticoagulation
Monday, June 26, 202318:30 – 19:30 ET